Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 2.68 USD -0.74% Market Closed
Market Cap: 122.9m USD
Have any thoughts about
Repro Med Systems Inc?
Write Note

Intrinsic Value

KRMD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one KRMD stock under the Base Case scenario is 3.16 USD. Compared to the current market price of 2.68 USD, Repro Med Systems Inc is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KRMD Intrinsic Value
3.16 USD
Undervaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Repro Med Systems Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KRMD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KRMD?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Repro Med Systems Inc

Provide an overview of the primary business activities
of Repro Med Systems Inc.

What unique competitive advantages
does Repro Med Systems Inc hold over its rivals?

What risks and challenges
does Repro Med Systems Inc face in the near future?

Has there been any significant insider trading activity
in Repro Med Systems Inc recently?

Summarize the latest earnings call
of Repro Med Systems Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Repro Med Systems Inc.

Provide P/S
for Repro Med Systems Inc.

Provide P/E
for Repro Med Systems Inc.

Provide P/OCF
for Repro Med Systems Inc.

Provide P/FCFE
for Repro Med Systems Inc.

Provide P/B
for Repro Med Systems Inc.

Provide EV/S
for Repro Med Systems Inc.

Provide EV/GP
for Repro Med Systems Inc.

Provide EV/EBITDA
for Repro Med Systems Inc.

Provide EV/EBIT
for Repro Med Systems Inc.

Provide EV/OCF
for Repro Med Systems Inc.

Provide EV/FCFF
for Repro Med Systems Inc.

Provide EV/IC
for Repro Med Systems Inc.

Show me price targets
for Repro Med Systems Inc made by professional analysts.

What are the Revenue projections
for Repro Med Systems Inc?

How accurate were the past Revenue estimates
for Repro Med Systems Inc?

What are the Net Income projections
for Repro Med Systems Inc?

How accurate were the past Net Income estimates
for Repro Med Systems Inc?

What are the EPS projections
for Repro Med Systems Inc?

How accurate were the past EPS estimates
for Repro Med Systems Inc?

What are the EBIT projections
for Repro Med Systems Inc?

How accurate were the past EBIT estimates
for Repro Med Systems Inc?

Compare the revenue forecasts
for Repro Med Systems Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Repro Med Systems Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Repro Med Systems Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Repro Med Systems Inc compared to its peers.

Compare the P/E ratios
of Repro Med Systems Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Repro Med Systems Inc with its peers.

Analyze the financial leverage
of Repro Med Systems Inc compared to its main competitors.

Show all profitability ratios
for Repro Med Systems Inc.

Provide ROE
for Repro Med Systems Inc.

Provide ROA
for Repro Med Systems Inc.

Provide ROIC
for Repro Med Systems Inc.

Provide ROCE
for Repro Med Systems Inc.

Provide Gross Margin
for Repro Med Systems Inc.

Provide Operating Margin
for Repro Med Systems Inc.

Provide Net Margin
for Repro Med Systems Inc.

Provide FCF Margin
for Repro Med Systems Inc.

Show all solvency ratios
for Repro Med Systems Inc.

Provide D/E Ratio
for Repro Med Systems Inc.

Provide D/A Ratio
for Repro Med Systems Inc.

Provide Interest Coverage Ratio
for Repro Med Systems Inc.

Provide Altman Z-Score Ratio
for Repro Med Systems Inc.

Provide Quick Ratio
for Repro Med Systems Inc.

Provide Current Ratio
for Repro Med Systems Inc.

Provide Cash Ratio
for Repro Med Systems Inc.

What is the historical Revenue growth
over the last 5 years for Repro Med Systems Inc?

What is the historical Net Income growth
over the last 5 years for Repro Med Systems Inc?

What is the current Free Cash Flow
of Repro Med Systems Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Repro Med Systems Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Repro Med Systems Inc

Current Assets 20.3m
Cash & Short-Term Investments 11.5m
Receivables 4.1m
Other Current Assets 4.7m
Non-Current Assets 8.2m
PP&E 7.4m
Intangibles 754.4k
Other Non-Current Assets 99k
Current Liabilities 4.5m
Accounts Payable 975.2k
Accrued Liabilities 2.5m
Short-Term Debt 314.3k
Other Current Liabilities 622.1k
Non-Current Liabilities 3.7m
Long-Term Debt 316.6k
Other Non-Current Liabilities 3.3m
Efficiency

Earnings Waterfall
Repro Med Systems Inc

Revenue
28.5m USD
Cost of Revenue
-11.8m USD
Gross Profit
16.7m USD
Operating Expenses
-27m USD
Operating Income
-10.3m USD
Other Expenses
-3.5m USD
Net Income
-13.7m USD

Free Cash Flow Analysis
Repro Med Systems Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

KORU Medical Systems reported Q2 2024 revenues of $8.4 million, a 22% increase year-over-year. The core business grew by 20%, driven by SCIg market growth and geographic expansion. Success in their Novel Therapies pipeline, including a Phase III trial for a nephrology drug and regulatory clearance for the FreedomEdge Infusion System in Japan, boosted international growth by 46%. Operations improvements and higher gross margins reduced losses, steering towards breakeven cash flow by Q4. Updated 2024 guidance predicts revenues of $32-32.5 million and gross margins of 61-62%, reflecting strong market performance despite expected normalization in international sales.

What is Earnings Call?
Fundamental Scores

KRMD Profitability Score
Profitability Due Diligence

Repro Med Systems Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
21/100
Profitability
Score

Repro Med Systems Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

KRMD Solvency Score
Solvency Due Diligence

Repro Med Systems Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
74/100
Solvency
Score

Repro Med Systems Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KRMD Price Targets Summary
Repro Med Systems Inc

Wall Street analysts forecast KRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRMD is 3.67 USD with a low forecast of 3.03 USD and a high forecast of 4.2 USD.

Lowest
Price Target
3.03 USD
13% Upside
Average
Price Target
3.67 USD
37% Upside
Highest
Price Target
4.2 USD
57% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KRMD?

Click here to dive deeper.

Dividends

Repro Med Systems Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KRMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

KRMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Repro Med Systems Inc Logo
Repro Med Systems Inc

Country

United States of America

Industry

Health Care

Market Cap

122.4m USD

Dividend Yield

0%

Description

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

Contact

NEW YORK
Chester New York
24 Carpenter Rd
+18454692042.0
www.repro-med.com

IPO

1993-10-27

Employees

77

Officers

President, CEO & Director
Ms. Linda M. Tharby
CFO, Secretary & Treasurer
Mr. Thomas Adams
Chief Commercial Officer
Mr. Kenneth Miller
Chief Operating Officer
Mr. Christopher Pazdan
Vice President of Sales
Mr. Rob Cannon

See Also

Discover More
What is the Intrinsic Value of one KRMD stock?

The intrinsic value of one KRMD stock under the Base Case scenario is 3.16 USD.

Is KRMD stock undervalued or overvalued?

Compared to the current market price of 2.68 USD, Repro Med Systems Inc is Undervalued by 15%.

Back to Top